Certara, Inc. (NASDAQ:CERT) Receives Consensus Rating of “Hold” from Brokerages

Certara, Inc. (NASDAQ:CERT) has received a consensus rating of “Hold” from the eleven research firms that are covering the firm, Marketbeat Ratings reports. Seven research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $20.06.

A number of analysts recently commented on CERT shares. JMP Securities initiated coverage on Certara in a report on Thursday, April 4th. They set a “market perform” rating on the stock. SVB Leerink assumed coverage on shares of Certara in a research report on Monday, February 26th. They set a “market perform” rating and a $19.00 price target for the company. KeyCorp upgraded shares of Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 price objective for the company in a report on Wednesday, April 10th. Jefferies Financial Group boosted their target price on shares of Certara from $14.00 to $15.50 and gave the company a “hold” rating in a research note on Friday, March 1st. Finally, Barclays raised their price target on shares of Certara from $16.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Thursday, January 25th.

Certara Price Performance

CERT opened at $17.08 on Thursday. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.62 and a quick ratio of 2.62. The firm’s fifty day moving average price is $17.67 and its two-hundred day moving average price is $16.29. Certara has a 1 year low of $11.81 and a 1 year high of $24.64. The company has a market capitalization of $2.74 billion, a price-to-earnings ratio of -48.80, a P/E/G ratio of 1.71 and a beta of 1.63.

Certara (NASDAQ:CERT) last issued its quarterly earnings data on Thursday, February 29th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.04). Certara had a positive return on equity of 4.33% and a negative net margin of 15.62%. The firm had revenue of $88.01 million during the quarter, compared to the consensus estimate of $86.80 million. As a group, analysts anticipate that Certara will post 0.29 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Certara news, SVP Richard M. Traynor sold 3,000 shares of the business’s stock in a transaction on Monday, April 1st. The shares were sold at an average price of $18.00, for a total transaction of $54,000.00. Following the sale, the senior vice president now owns 173,524 shares of the company’s stock, valued at approximately $3,123,432. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, insider Patrick F. Smith sold 14,427 shares of the firm’s stock in a transaction that occurred on Tuesday, April 2nd. The shares were sold at an average price of $16.85, for a total value of $243,094.95. Following the completion of the transaction, the insider now directly owns 50,091 shares in the company, valued at $844,033.35. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Richard M. Traynor sold 3,000 shares of the company’s stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $18.00, for a total transaction of $54,000.00. Following the sale, the senior vice president now directly owns 173,524 shares in the company, valued at approximately $3,123,432. The disclosure for this sale can be found here. In the last ninety days, insiders sold 23,427 shares of company stock valued at $405,095. Company insiders own 2.39% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Motley Fool Asset Management LLC boosted its stake in Certara by 2.0% during the third quarter. Motley Fool Asset Management LLC now owns 45,890 shares of the company’s stock valued at $667,000 after buying an additional 890 shares during the period. Comerica Bank raised its holdings in shares of Certara by 1.7% in the 4th quarter. Comerica Bank now owns 55,469 shares of the company’s stock valued at $976,000 after acquiring an additional 929 shares in the last quarter. Pineridge Advisors LLC bought a new stake in shares of Certara during the 4th quarter valued at about $28,000. Global Retirement Partners LLC grew its holdings in shares of Certara by 5,306.3% during the first quarter. Global Retirement Partners LLC now owns 1,730 shares of the company’s stock worth $31,000 after purchasing an additional 1,698 shares in the last quarter. Finally, Natixis Advisors L.P. increased its position in shares of Certara by 13.4% in the third quarter. Natixis Advisors L.P. now owns 15,136 shares of the company’s stock worth $220,000 after purchasing an additional 1,791 shares during the last quarter. 73.96% of the stock is currently owned by hedge funds and other institutional investors.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.